🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Sanaria PfSPZ Vaccines Wins Highly Commended Prophylactic Vaccine at the 13th Annual Vaccine Industry Excellence Awards sanaria.com/2020/09/30/san…

Sanaria entered into a contract to receive €12.9M for the development of two Malaria vaccines, one Malaria prophylactic, and a SARS-CoV-2 vaccine from the EU Malaria Fund (EUMF) sanaria.com/2020/11/05/eu-…

Sanaria and its collaborators optimizing PfSPZ vaccines. Two recent malaria vaccine studies moved the process forward and highlighted the high protective efficacy of Sanaria® PfSPZ-CVac in malaria-naïve adults. sanaria.com/2021/06/08/opt… UW Dept. of Laboratory Medicine and Pathology 🔬 DZIF (inaktiv) KP WA Research

Sanaria VaccineTrial Results Demonstrate Unprecedented Progress in Worldwide Battle Against Variant Malaria Parasites NIH NIAID News Press Release: sanaria.com/2021/06/30/san…

Sanaria Inc. and Seattle Children's Announce Collaboration For Development of Genetically Attenuated Malaria Vaccines sanaria.com/2021/10/19/san…

Pregnancy malaria is huge problem. Sanaria pleased to contribute to symposium 52 #TropMed21 annual meeting showing potential of PfSPZ Vaccine in women of childbearing potential. Halimatou Diawara will present exciting data on trials of PfSPZ Vaccine in pregnant women

Oral vaccination against COVID-19 is becoming possible. Presentation 473 by Kim Lee Sim will describe the platform technology and the approach being taken by Sanaria and Protein Potential in this exciting arena #TropMed21

Infectious Malaria Sporozoites Produced Without Mosquitoes Provide Ground-Breaking Progress for Malaria Vaccines and Biology Research Nature article: rdcu.be/c1bj7 Press Release: sanaria.com/2022/12/07/inf…

Sanaria up for Best Logistics & Cold Chain Delivery Award at the Vaccine Industry Excellence Awards - please vote for us! form.jotform.com/230213332871345

Sanaria has recently received $1.5M from the Bill & Melinda Gates Foundation as the first step towards a repository of PfSPZ Challenge material. Thank you for being part of our network and supporting our goal of malaria eradication sanaria.com/2023/11/27/san…

Sanaria® PfSPZ-LARC2 Vaccine: finalist in Vaccine Industry Excellence (VIE) awards for Best Prophylactic Vaccine Award sanaria.com/2024/03/07/san…

Sanaria is a finalist in Vaccine Industry Excellence (VIE) awards for Best Logistics Technology & Cold Chain Delivery Award sanaria.com/2024/03/06/san…

Novel vaccine, PfSPZ-LARC2 Vaccine, to prevent malaria infection developed by Seattle Children’s Research Institute and Sanaria ready for human testing Seattle Children's sanaria.com/2024/04/01/nov…

Sanaria Wins Best Logistics Technology and Cold Chain Delivery Award at the Vaccine Industry Excellence (ViE) Awards sanaria.com/2024/04/03/san…

Indonesian collaborators and stake holders attend meeting in Jakarta to report successful results of trial of PfSPZ vaccines in Indonesian soldiers. sanaria.com/2024/07/24/ind…

First-of-its-kind vaccine expands malaria protection for pregnant women sanaria.com/?p=4527 NIAID News PMRTC

The long road to a malaria vaccine that’s safe during pregnancy devex.com/news/the-long-… #Devex via Devex

A Single-Dose Breakthrough: PfSPZ-LARC Vaccines Offer Transformative Protection Against Malaria sanaria.com/2025/02/12/a-s… Seattle Children's

Sanaria has been nominated for Best Biotech Award from the Vaccine Industry Excellence awards. Please vote for Sanaria for Best Biotech Award! terrapinn-awards.evessiocloud.com/vieawards2025/…

Sanaria Reports Positive Initial Safety Results for Groundbreaking PfSPZ-LARC2 Malaria Vaccine sanaria.com/2025/06/03/san…